Printer Friendly

COMPANY INFORMATION
Adherex Technologies Inc. 4620 Creekstone Dr, Suite 200 Durham, NC, United States 27703 Tel: (919) 484-8484 Fax: (919) 484-8001 Contact Name Rosty Raykov Industry Biotechnology		Key Executives Rosty Raykov, CEO Robert Andrade, CFO Develops therapeutic products for treatment of various types of cancer.
FP ADVISOR COVERAGE Adherex Technologies Inc. • FP Corporate Analyzer • FP Directory of Directors • FP Corporate Surveys • Ordering FP Products		TOP INDUSTRY PLAYERS Biotechnology Company Name Revenue ($000s)  Atrium Innovations Inc. 309,546 Angiotech Pharmaceuticals, Inc. 302,251 QLT Inc. 132,457 Oncothyreon Inc. 42,678 AEterna Zentaris Inc. 41,056 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX/AHX $0.04 $0.11 $0.01 n.a. n.a. n.a. 1.32 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 18,432 n.a. US$-0.04 Sept. 30/09 33.33% -51.93% -53.55% $5,129
ANNUAL FINANCIALS Periods ended: 12m Dec. 31/08A 12m Dec. 31/07A 12m Dec. 31/06 US$000s US$000s US$000s Net income (13,600) (13,357) (19,103) Total assets 6,060 17,209 16,584 US$ US$ US$ Earnings per share* (0.11) (0.11) (0.40) % % % Return on equity (158.13) (122.92) (138.22)   * Common A Reported in accordance with U.S. GAAP
TRAILING 12-MONTH VALUES Periods ended: Sept. 30/09A Sept. 30/08A US$000s US$000s Net income (6,470) (13,998) US$ US$ Earnings per share (0.05) (0.11)   A Reported in accordance with U.S. GAAP

COMPANY NEWS

Results for 'Adherex Technologies Inc.' from past 30 days: No hits. (Links are to articles.)